Approval · Notice of Compliance 2639 · 2001
MAVIK: Notice of Compliance 2639
Issued June 13, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2639
- Date
- June 13, 2001
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer's name
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
Medicinal ingredients
- TRANDOLAPRIL 0.5 MG per CAP
- TRANDOLAPRIL 1 MG per CAP
- TRANDOLAPRIL 2 MG per CAP
- TRANDOLAPRIL 4 MG per CAP